Robot takes the scalpel: new study tests versius for hysterectomy
NCT ID NCT07289295
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a surgical robot called Versius to see if it is safe and effective for performing hysterectomies (removal of the uterus). The study will enroll 45 women who need this surgery for non-cancer reasons. The main goals are to see how often the surgery is completed successfully with the robot and to track any serious side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ROBOTIC ASSISTED HYSTERECTOMY AND/OR SALPINGO-OOPHORECTOMY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Uniwersyteckie Centrum Kliniczne im. prof. K. Gibińskego Śląskiego Uniwersytetu Medycznego w Katowicach
RECRUITINGKatowice, 40-572, Poland
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••